VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Baxfendy

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

THE FIRST AND ONLY FDA-APPROVED ALDOSTERONE SYNTHASE INHIBITOR

  • Biotech & therapeutics
Claim, correct or request removal

Record updated 17 September 2026

About

BAXFENDY DELIVERED double-digit absolute reductions in systolic blood pressure in adults who were not adequately controlled on other agents

Products

Other
BAXFENDY
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy